CN102127032A - Method for synthesizing poly-substituted 5-acyl-2-imine thiazoline - Google Patents

Method for synthesizing poly-substituted 5-acyl-2-imine thiazoline Download PDF

Info

Publication number
CN102127032A
CN102127032A CN2011100233968A CN201110023396A CN102127032A CN 102127032 A CN102127032 A CN 102127032A CN 2011100233968 A CN2011100233968 A CN 2011100233968A CN 201110023396 A CN201110023396 A CN 201110023396A CN 102127032 A CN102127032 A CN 102127032A
Authority
CN
China
Prior art keywords
ether solvent
reaction
formula
synthetic method
thiazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2011100233968A
Other languages
Chinese (zh)
Other versions
CN102127032B (en
Inventor
张文雄
王杨
席振峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University
Original Assignee
Peking University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University filed Critical Peking University
Priority to CN 201110023396 priority Critical patent/CN102127032B/en
Publication of CN102127032A publication Critical patent/CN102127032A/en
Application granted granted Critical
Publication of CN102127032B publication Critical patent/CN102127032B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a method for synthesizing poly-substituted 5-acyl-2-imine thiazoline, which belongs to the field of organic synthesis. The method comprises the following steps of: (a) making carbodiimide shown as a formula I react with acyl chloride shown as a formula II in an ether solvent I at the reaction temperature of between 25 DEG C and the boiling point of the ether solvent I; (b) making a terminal alkyne compound shown as a formula III react with an alkyl metal compound in an ether solvent II at the reaction temperature of between the freezing point of the ether solvent II and 0 DEG C, adding a sulfur simple substance for continually reacting and naturally raising the temperature to room temperature; (c) adding reaction liquid obtained in the step (a) into reaction liquid obtained in the step (b) and raising the reaction temperature to 60-100 DEG C; and (d) performing post-treatment on the reaction liquid to obtain the poly-substituted 5-acyl-2-imine thiazoline shown as a formula IV. The reaction formula is shown in the specifications. The method can be applied to the fields of pesticides, medicaments and the like.

Description

The synthetic method of a kind of polysubstituted 5-acyl group-2-imines thiazoline
Technical field
The present invention relates to have the universal synthesis method of multiple substituent 5-acyl group-2-imines thiazoline derivative, belong to the organic synthesis field.
Background technology
Have multiple substituent 5-acyl group-2-imines thiazoline derivative and in agriculture production, have higher desinsection, antibacterial and weeding activity; secretion that simultaneously can the coordinate plant growth hormone; as promote the activity of taking root of plant cotyledon, be efficient, the environment amenable pesticide molecule of a class.5-acyl group-2-imines thiazoline derivative is lower to the toxicity of human body, so more application is also arranged in medicine, has higher biological activity, and kinase inhibiting activity that it had and platelet aggregation inhibitory activity make it become potential medicine lead compound.In the synthetic method of 5-acyl group-2-imines thiazoline derivative that present document provides, the synthetic difficulty of starting raw material is big, complex operation, and the substrate scope is subjected to bigger restriction.The present invention then provides a kind of and carries out the synthetic method from general industrial chemicals, the efficient height, and cost is low, compared with existent method, has bigger application prospect and value.
Summary of the invention
The purpose of this invention is to provide a kind of synthetic universal method of multiple substituent 5-acyl group-2-imines thiazoline derivative that has.Technical scheme of the present invention is as follows:
The method of a kind of synthetic polysubstituted 5-acyl group-2-imines thiazoline derivative may further comprise the steps:
A) acyl chlorides shown in carbodiimide shown in the formula I and the formula II is reacted in ether solvent one, temperature of reaction is between the boiling point of 25 ℃ and described ether solvent one;
B) terminal alkyne compound shown in the formula III and alkide are reacted in ether solvent two, temperature of reaction is between the zero pour of described ether solvent two and 0 ℃; Add sulphur simple substance and continue reaction, be warming up to room temperature naturally;
C) a) reaction solution is added to b) reaction solution in, temperature of reaction is risen to 60-100 ℃;
D) reaction solution obtains the polysubstituted 5-acyl group-2-imines thiazoline shown in the formula IV through aftertreatment.
The primitive reaction formula of above-mentioned reaction process is as follows:
Wherein:
R 1And R 2Can be the same or different, independently of one another expression:
Carbonatoms is 1-12 or more alkyl, such as: methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-..., undecyl, dodecyl, tridecyl ..., octadecyl etc., more preferably C1-6 alkyl, more preferably C1-4 alkyl;
Carbonatoms is the cycloalkyl of 3-6, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
Carbonatoms is the aryl of 6-12, such as phenyl, xenyl, naphthyl etc.;
Or carbonatoms is the heterocyclic aryl of 2-5, such as thienyl, thiazolyl, pyridyl etc.
Above-mentioned group can be substituted base and replace, and described substituting group can be common C1-4 alkyl or alkoxyl group, C4-6 cycloalkyl, halogen atom (F, Cl, Br, I), cyano group, nitro or the like.
R 3Expression:
Carbonatoms is 1-12 or more alkyl, such as: methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-..., undecyl, dodecyl, tridecyl ..., octadecyl etc., more preferably C1-6 alkyl, more preferably C1-4 alkyl;
Carbonatoms is the cycloalkyl of 3-6, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
Carbonatoms is the aryl of 6-12, such as phenyl, xenyl, naphthyl etc.;
Or carbonatoms is the heterocyclic aryl of 2-5, such as thienyl, thiazolyl, pyridyl etc.
Above-mentioned group can be substituted base and replace, and described substituting group can be common C1-4 alkyl or alkoxyl group, C4-6 cycloalkyl, halogen atom (F, Cl, Br, I), cyano group, nitro or the like.
R 4Expression:
Carbonatoms is 1-12 or more alkyl, such as: methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-..., undecyl, dodecyl, tridecyl ..., octadecyl etc., more preferably C1-6 alkyl, more preferably C1-4 alkyl;
Carbonatoms is the cycloalkyl of 3-6, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
Carbonatoms is the aryl of 6-12, such as phenyl, xenyl, naphthyl etc.;
Or carbonatoms is the heterocyclic aryl of 2-5, such as thienyl, thiazolyl, pyridyl etc.
Above-mentioned group can be substituted base and replace, and described substituting group can be common C1-4 alkyl or alkoxyl group, C4-6 cycloalkyl, halogen atom (F, Cl, Br, I), cyano group, nitro or the like.
Preferred n-Butyl Lithium of alkide RM used in the present invention or tert-butyl lithium, useful commercial reagent need not special processing.
Ether solvent used in the present invention, promptly ether solvent one and ether solvent two can be alkyl oxide, aryl oxide or cyclic ethers, can be a kind of ether, also can be the mixtures of multiple ether, ether solvent commonly used is ether, tetrahydrofuran (THF), methyltetrahydrofuran etc. for example.This ether solvent useful commercial reagent is back to mazarine through sodium-benzophenone before using and steams and get final product.The moiety of described ether solvent one and ether solvent two can be identical, also can be different, and have no special requirements.
The mol ratio preferable range of various reaction raw materials of the present invention or reagent is as shown in table 1:
The preferred molar ratio of various reaction raw materials of table 1. or reagent
Raw material or reagent Carbodiimide Acyl chlorides Terminal alkyne compound Alkide Ether solvent S 8
Molar equivalent 1 1-1.2 1-1.2 1-1.2 Arbitrarily 0.125-0.15
The inventive method is not particularly limited the ratio of terminal alkyne compound and ether solvent, as long as reaction solution is evenly stirred, the terminal alkyne compound of preferred 1mmol is dissolved in the ether solvent of volume greater than 2mL.
It is how much slightly different according to different raw materials that the inventive method respectively goes on foot the reaction times, detects to disappear with raw material to be as the criterion general 10-12 hour.
Steps d of the present invention can adopt oil bath (for example silicone oil, paraffin wet goods) or other modes to heat, as long as maintain temperature of reaction.
The normally simple reaction solution of aftertreatment concentrates, and the reaction solution concentration process can adopt methods such as air distillation, underpressure distillation, or for example concentrates with Rotary Evaporators.
In order to obtain more highly purified product, preferably the product after the aftertreatment is carried out purifying, described purge process can be made eluent with certain polar solvent, and the chromatographic column separation gets final product.Selected eluent has certain difference according to the opposed polarity of product.Generally speaking, to select volume ratio for use be sherwood oil to eluent: methylene dichloride=1: 1.The chromatographic column of using such as laboratory silicagel column commonly used or high performance liquid chromatography etc.
The present invention utilizes carbodiimide, acyl chlorides, terminal alkyne compound and elemental sulfur to prepare 5-acyl group-2-imines thiazoline derivative; productive rate is higher; synthetic method is scientific and reasonable, thereby provides one synthetic to have a universal method of multiple substituent 5-acyl group-2-imines thiazoline derivative.This method raw material is easy to get, and is applied widely, high isolated yield, and experimental installation and operation is simple is convenient to further Application and Development.
Embodiment
Further describe the present invention below in conjunction with embodiment, but the scope that does not limit the present invention in any way.
Embodiment 1---preparation formula IVa (R 1=R 2= iPr, R 3=4-CF 3-Ph, R 4=Ph) compound:
Figure BDA0000044653330000041
Under nitrogen protection, in the reaction tubes of the 20mL that the 3mL ether is housed, add 1mmol N, N '-DIC and 1mmol 4-trifluoromethyl benzoyl chloride, 25 ℃ of reaction 48h.Under nitrogen protection, in the reaction tubes of the 20mL that the 2mL ether is housed, add the 1mmol phenylacetylene, it is constant in-78 ℃ with temperature of reaction to adopt dry ice-propanone to bathe, and drips the 1mmol n-Butyl Lithium, adds afterreaction half an hour, adds 0.125mmol S 8, be warming up to 25 ℃ naturally, magnetic agitation reaction two hours.Above-mentioned two kinds of reaction solns are mixed, and 80 ℃ were reacted 10 hours.Reaction solution concentrates, the silicagel column decolouring separates, use sherwood oil: the mixed solvent of methylene dichloride=1: 1 is made eluent, obtain thiazoline derivative 3-sec.-propyl-2-sec.-propyl imido grpup-4-phenyl-2,3-thiazoline-5-thiazolinyl-(4-trifluoromethyl)-benzophenone 355mg (purity>98%, yellow solid), isolated yield 82%.The nuclear magnetic data of this compound is as follows: 1H NMR (400MHz, CDCl 3, Me 4Si): δ 1.21 (d, J=6.2Hz, 6H, CH 3), 1.44 (d, J=6.8Hz, 6H, CH 3), 3.19 (m, 1H, CH), 3.89 (m, 1H, CH), 6.96-7.20 (m, 10H, CH); 13C NMR (100MHz, CDCl 3, Me 4Si): δ 18.99,22.97,51.21,56.59,112.57,127.24,127.64,128.11,129.30,129.47,129.89,130.71,139.13,150.19,151.24,187.69.
Embodiment 2---preparation formula IVb (R 1=R 2=Cy, R 3=3-MeO-Ph, R 4=3-thienyl) compound:
Figure BDA0000044653330000042
Under nitrogen protection, in the reaction tubes of the 20mL that the 4mL ether is housed, add 1mmol N, N '-dicyclohexylcarbodiimide and 1.2mmol 3-methoxy benzoyl chloride, 25 ℃ of reaction 48h.Under nitrogen protection, in the reaction tubes of the 20mL that the 3mL tetrahydrofuran (THF) is housed, add 1mmol 3-thienyl acetylene, drip the 1mmol n-Butyl Lithiums, add afterreaction half an hour, add 0.15mmol S at-78 ℃ 8, be warming up to about 25 ℃ magnetic agitation reaction two hours.Above-mentioned two kinds of reaction solns are mixed, and 80 ℃ were reacted 10 hours.Reaction solution concentrates, the silicagel column decolouring separates, use sherwood oil: the mixed solvent of methylene dichloride=1: 1 is made eluent, obtain straight product 3-cyclohexyl-2-cyclohexyl imido grpup-4-phenyl-2,3-thiazoline-5-thiazolinyl-(4-methoxyl group)-benzophenone 347mg (purity>98%, yellow solid), isolated yield 75%.The nuclear magnetic data of this compound is as follows: 1H NMR (400MHz, CDCl 3, Me 4Si): δ 0.83-1.15 (m, 4H, CH 2), 1.37-1.59 (m, 8H, CH 2), 1.71-1.82 (m, 6H, CH 2), 2.17 (s, 3H, CH 3), 2.73-2.80 (m, 2H, CH 2), 2.90-2.96 (m, 1H, CH), 3.43-3.51 (m, 1H, CH), 6.87-7.19 (m, 7H, CH); 13C NMR (75MHz, CDCl 3, Me 4Si): δ 21.42,24.72, and 25.42,26.45,26.49,28.78,33.18,60.08,64.23,114.16,125.22,126.69,127.93 (2CH), 128.68,128.77,130.56,131.30,137.23,139.33,145.55,151.46,188.53.
Embodiment 3---preparation formula IVc (R 1=R 2Cy, R 3=2-thienyl, R 4=4-Me-Ph) compound:
Figure BDA0000044653330000051
With embodiment 1, aftertreatment is identical substantially for synthetic route.This synthetic raw material that sets out is the 4-methylbenzene acetylene of 1.1mmol, the N of 1mmol, N '-dicyclohexylcarbodiimide, 1.1mmol 2-thiophene acyl chlorides, use the 1mmol n-Butyl Lithium, obtain straight product 3-cyclohexyl-2-cyclohexyl imido grpup-4-(4-methyl)-phenyl-2,3-thiazoline-5-thiazolinyl-(2-thienyl)-ketone 333mg (purity>98%, yellow solid), isolated yield 72%.The nuclear magnetic data of this compound is as follows: 1H NMR (400MHz, CDCl 3, Me 4Si): δ 0.83-1.80 (m, 18H, CH 2), 2.35 (s, 3H, CH 3), 2.71-2.80 (m, 2H, CH 2), 2.91-2.96 (m, 1H, CH), 3.48-3.56 (m, 1H, CH), 6.82-7.40 (m, 7H, CH); 13C NMR (75MHz, CDCl 3, Me 4Si): δ 21.36,24.24,24.98,25.95,25.99,28.09,32.73,59.17,63.77,108.43,127.00,128.65,128.96,129.21,131.28,131.52,139.27,144.65,150.71,150.75,177.39.
Embodiment 4---preparation formula IVd (R 1=Cy, R 2=Ph, R 3=4-CF 3-Ph, R 4=cyclohexenyl) compound:
Figure BDA0000044653330000052
With embodiment 1, aftertreatment is identical substantially for synthetic route.This synthetic raw material that sets out is the cyclohexenyl acetylene of 1mmol, the 1-cyclohexyl 3-phenyl carbons diimine of 1mmol, the 4-trifluoromethyl benzoyl chloride of 1mmol, use the 1.2mmol tert-butyl lithium, obtain straight product 316mg (purity>98%, yellow solid), isolated yield 62%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CDCl 3, Me 4Si): δ 0.84-2.01 (m, 16H, CH 2), 2.79-2.99 (m, 2H, CH 2), 3.63-3.72 (m, 1H, CH), 5.69 (s, 1H, CH), 7.01-7.62 (m, 9H, CH); 13C NMR (75MHz, CDCl 3, Me 4Si): δ 20.50,21.80, and 24.89,25.10,26.34,26.50,28.18,28.85,28.94,60.48,111.85,120.81,123.64,123.67 (q, J C-F=270.1Hz), 124.88 (q, J C-F=3.7Hz), 127.57,128.10,129.56,131.88 (q, J C-F=32.3Hz), and 135.77,144.05,150.90,153.57,155.73,186.84.
Embodiment 5---preparation formula IVe (R 1=R 2=2-pyridyl, R 3= nPr, R 4=Ph) compound:
Figure BDA0000044653330000061
With embodiment 1, aftertreatment is identical substantially for synthetic route.The synthetic raw material that sets out is the phenylacetylene of 1mmol, the N of 1mmol, N '-two (2-pyridyl) carbodiimide, the n-butyryl chloride of 1mmol uses the 1.2mmol n-Butyl Lithium, and the straight product that obtains at last is 269mg (purity>98%, yellow solid), isolated yield 67%.

Claims (7)

1. the synthetic method of polysubstituted 5-acyl group-2-imines thiazoline is characterized in that, comprises the following steps:
A) acyl chlorides shown in carbodiimide shown in the formula I and the formula II is reacted in ether solvent one, temperature of reaction is between the boiling point of 25 ℃ and described ether solvent one;
B) terminal alkyne compound shown in the formula III and alkide are reacted in ether solvent two, temperature of reaction is between the zero pour of described ether solvent two and 0 ℃; Add sulphur simple substance and continue reaction, be warming up to room temperature naturally;
C) a) reaction solution is added to b) reaction solution in, temperature of reaction is risen to 60-100 ℃;
D) reaction solution obtains the polysubstituted 5-acyl group-2-imines thiazoline shown in the formula IV through aftertreatment;
Figure FDA0000044653320000011
Wherein, R 1, R 2, R 3And R 4The C of expression replacement independently of one another or non-replacement 1-12Alkyl, C 3-6Cycloalkyl, C 6-12Aryl or C 2-5Heterocyclic aryl.
2. synthetic method as claimed in claim 1 is characterized in that, described alkide is n-Butyl Lithium or tert-butyl lithium.
3. synthetic method as claimed in claim 1 is characterized in that, described ether solvent one and ether solvent two are selected from independently of one another: alkyl oxide, aryl oxide or cyclic ethers or their mixture.
4. synthetic method as claimed in claim 3 is characterized in that, described ether solvent one and ether solvent two are selected from independently of one another: ether, tetrahydrofuran (THF), methyltetrahydrofuran or their mixture.
5. synthetic method as claimed in claim 1 is characterized in that, described carbodiimide, and acyl chlorides, terminal alkyne compound, alkide, the molar equivalent ratio of sulphur simple substance is 1: (1-1.2): (1-1.2): (1-1.2): (0.125-0.15).
6. synthetic method as claimed in claim 1 is characterized in that, described aftertreatment comprises that reaction solution concentrates, and concentration process adopts air distillation, underpressure distillation or evaporates with Rotary Evaporators.
7. synthetic method as claimed in claim 1 is characterized in that, by chromatographic column separation and purification product, eluent is that volume ratio is 1: 1 sherwood oil and a methylene dichloride mixed solvent.
CN 201110023396 2011-01-20 2011-01-20 Method for synthesizing poly-substituted 5-acyl-2-imine thiazoline Expired - Fee Related CN102127032B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110023396 CN102127032B (en) 2011-01-20 2011-01-20 Method for synthesizing poly-substituted 5-acyl-2-imine thiazoline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110023396 CN102127032B (en) 2011-01-20 2011-01-20 Method for synthesizing poly-substituted 5-acyl-2-imine thiazoline

Publications (2)

Publication Number Publication Date
CN102127032A true CN102127032A (en) 2011-07-20
CN102127032B CN102127032B (en) 2013-03-06

Family

ID=44265344

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110023396 Expired - Fee Related CN102127032B (en) 2011-01-20 2011-01-20 Method for synthesizing poly-substituted 5-acyl-2-imine thiazoline

Country Status (1)

Country Link
CN (1) CN102127032B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232406A (en) * 2013-04-26 2013-08-07 北京大学 1, 3-thiazole derivative

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097007A (en) * 1992-12-04 1995-01-04 住友化学工业株式会社 Prepare the method for 2-iminothiazoline derivatives and the method for its middle product of preparation
WO2007122241A1 (en) * 2006-04-26 2007-11-01 Glaxo Group Limited Compounds which potentiate ampa receptor and uses thereof in medicine
CN101768134A (en) * 2009-12-31 2010-07-07 浙江医药高等专科学校 2-imido-3-(substituted phenyl)-4-methyl-5-acetyl-4-thiazoline and synthesis method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097007A (en) * 1992-12-04 1995-01-04 住友化学工业株式会社 Prepare the method for 2-iminothiazoline derivatives and the method for its middle product of preparation
WO2007122241A1 (en) * 2006-04-26 2007-11-01 Glaxo Group Limited Compounds which potentiate ampa receptor and uses thereof in medicine
CN101768134A (en) * 2009-12-31 2010-07-07 浙江医药高等专科学校 2-imido-3-(substituted phenyl)-4-methyl-5-acetyl-4-thiazoline and synthesis method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232406A (en) * 2013-04-26 2013-08-07 北京大学 1, 3-thiazole derivative

Also Published As

Publication number Publication date
CN102127032B (en) 2013-03-06

Similar Documents

Publication Publication Date Title
CN106928117A (en) A kind of preparation method of deuterated aromatics organic compound
CN104926811B (en) The synthetic method of 3-cyanoimidazole also [1,2-a] pyridine compounds and application thereof
CN109336808A (en) The green new method of transition metal-catalyzed C-H carbenoid coupling reaction synthesis C-C key and N heterocyclic derivative
CN1072213C (en) Process for producing guanidine derivatives, intermediates therefor and their production
CN105218540A (en) The preparation method of a kind of C-3 position thiocarbamoyl imidazole also [1,2-a] pyridine compounds and their
CN102127032B (en) Method for synthesizing poly-substituted 5-acyl-2-imine thiazoline
Murai et al. Imidazo [1, 5-a] pyridine-1-ylalkylalcohols: synthesis via intramolecular cyclization of N-thioacyl 1, 2-aminoalcohols and their silyl ethers and molecular structures
CN104610267B (en) Method for efficiently synthesizing 6-alkyl pyrazolo [1,5-c ] quinazoline framework compound under non-catalytic condition
CN108689892B (en) 3-sulfonylation-indanone compound and preparation method thereof
JP2022516863A (en) Preparation of sulfonamide herbicide process intermediate products
CN109897033A (en) A kind of method synthesizing imidazo containing iodine [1,2a] pyridine compounds and their
CN105272918B (en) Halogenation -1- alkyl -3- vinyl -2,4,5- triarylimidazoles and preparation method and purposes
CN104327025B (en) A kind of preparation method of 4-arylnaphthalene lactone derivative
CN107459536A (en) A kind of green synthesis method of 4 ferrocenyl quinoline
CN108929251B (en) Method for direct trifluoromethylation of C (sp3) -H
CN103232406B (en) A kind of 1,3-thiazoles derivative
CN103214394B (en) A kind of Alkynyl imine derivative
CN105254530A (en) Method for synthesizing Schiff base compound containing camphenyl
CN110156668A (en) A method of synthesis 4- Polyfluoroalkyl -2,6- diaryl substituted pyridine compound
CN101643450B (en) Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone
CN110590621B (en) Method for synthesizing 1, 2-bis (arylsulfonyl) ethylene derivative by copper-catalyzed terminal alkyne
CN103755667B (en) A kind of chirality 3-(2-nitro-ethyl) tetrahydrofuran-compound and preparation method thereof
CN111253313B (en) Method for preparing pyrazole amide compound by utilizing microreactor
CN101357902B (en) Method for preparing N- formyl-2H-4chloroquinoline derivate
CN113735850A (en) Synthesis method of 1,2, 4-triazole compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130306

Termination date: 20190120

CF01 Termination of patent right due to non-payment of annual fee